Compare Alcon AG (ALC) vs Visa Inc (V) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Visa Inc — how do they compare? Alcon AG trades at $66.96 (market cap $32.69B), while Visa Inc trades at $347.92 (market cap $669.79B). The key difference: Visa Inc is far larger — about 20.5× Alcon AG's market cap, and Visa Inc pays the higher dividend (0.76%). Which is the better fit depends on your goals.
| ALC | V | |
|---|---|---|
Market Cap | $32.69B | $669.79B |
Sector | Health | Financials |
52-Week High | $92.22 | $362.13 |
52-Week Low | $62.02 | $295.52 |
Enterprise Value | $36.28B | $680.39B |
Dividend Yield | 0.54% | 0.76% |
Volume | — | 10,431,336 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Visa (V) trades at $348.16, down 2.54% over the past day, with a bullish technical outlook and strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.31 surpassing the $3.10 expectation. Revenue grew to $40 billion in 2025, supporting a net income margin of 51.68%. Analyst sentiment remains overwhelmingly positive, with 85% recommending Buy and a consensus price target of $392.50, suggesting 13% upside. Recent news highlights Visa's push into AI-driven commerce and stablecoin partnerships.
Visa presents a favorable long-term investment opportunity due to its robust profitability, expanding revenue, and strategic initiatives in digital payments. Risks include competitive pressures from fintech and regulatory scrutiny, but strong institutional support and consistent earnings growth underpin a positive outlook. The current valuation, while premium, is justified by high margins and market leadership.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →
